HF
TLSIW icon

HRT Financial’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

HRT Financial’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-21,253
Closed -$23K – 3385
2024
Q4 		$23K Sell
21,253
-6,997
-25% -$8.31K ﹤0.01% 2189
2024
Q3 		$29K Sell
28,250
-1,681
-6% -$2.26K ﹤0.01% 2160
2024
Q2 		$54K Sell
29,931
-25
-0.1% -$34 ﹤0.01% 1826
2024
Q1 		$29K Buy
29,956
+25
+0.1% +$25 ﹤0.01% 1980
2023
Q4 		$35K Hold
29,931
– – ﹤0.01% 1990
2023
Q3 		$11K Sell
29,931
-110
-0.4% -$24 ﹤0.01% 2118
2023
Q2 		$1K Buy
30,041
+110
+0.4% +$7 ﹤0.01% 2317
2023
Q1 		$1K Sell
29,931
-100
-0.3% -$9 ﹤0.01% 2378
2022
Q4 		$2K Buy
30,031
+14,571
+94% +$988 ﹤0.01% 2336
2022
Q3 		$0 Hold
15,460
– – ﹤0.01% 3507
2022
Q2 		$1K Hold
15,460
– – ﹤0.01% 2818
2022
Q1 		$3K Buy
15,460
+2,700
+21% +$1.16K ﹤0.01% 2980
2021
Q4 		$6K Buy
+12,760
New +$11.7K ﹤0.01% 3044

Other funds holding TLSIW

GL
Graypoint LLC Albany, New York $1.78B AUM 16.72% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
ACM
Alpha Capital Management Austin, Texas $690M AUM 22.82% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.75B AUM 18.02% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HRT Financial's TLSIW Position: Q1 2025 in Review

HRT Financial sold out of TriSalus Life Sciences Warrant (TLSIW) in Q1 2025, closing a stake of 21,253 shares — an estimated $23K sold.

HRT Financial first reported a position in TLSIW in Q4 2021 and held it in 13 quarters. The position peaked at $54K in Q2 2024. 6 funds tracked by Wall St. Rank hold TLSIW as of Q1 2025.

  • HRT Financial reported no remaining TriSalus Life Sciences Warrant position as of Q1 2025 after selling out during the quarter.
  • HRT Financial sold 21,253 TriSalus Life Sciences Warrant shares in Q1 2025, an estimated $23K.
  • HRT Financial first reported a position in TriSalus Life Sciences Warrant in Q4 2021 and held it in 13 quarters.
  • HRT Financial's TriSalus Life Sciences Warrant position peaked at $54K in Q2 2024.
  • 6 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.